Tata Chemicals Limited · NSE:TATACHEM
Tata Chemicals — Q4 FY2018 Earnings Presentation
17 slides from Tata Chemicals's earnings presentation, May 18, 2018
Slide 1: Submission letter to stock exchanges
.-\ TI' TATA May 18,2018 The Secretary, Listing Department The Manager, Listing Department BSE Limited National Stock Exchange of lndia Ltd Phiroze Jeejeebhoy Towers Exchange Plaza, 5th Floor, Plot No. C/1 Dalal Street G Block, Bandra-Kurla Complex Mumbai 400 001 Bandra (E) Scrio Code: 500770 Mumbai
Slide 2: Analyst / Investors Communication on Financial Results Q4 and 12 Months ended 31st March 2018
Analyst / Investors Communication on Financial results for the period Q4 and 12 Months ended 31st March 2018 Dated: 18 th May 2018
Slide 3: Safe Harbour Statement
Safe Harbour Statement “This Presentation, except for the historical information, may contain statements, including the words or phrases such as ‘expects, anticipates, intends, will, would, undertakes, aims, estimates, contemplates, seeks to, objective, goal, projects, should’ and similar expression
Slide 4: Key Highlights - Continuing Operations (Q4)
Key Highlights - Continuing Operations Q4 Mar 18 vs. Q4 Mar 17 Consolidated Revenue down by Rs 37 Cr to Rs 2,555 Cr (↓ 1 % as compared to Q4 FY2017) Standalone Revenue down by Rs 21 Cr to Rs 918 Cr (↓ 2 % as compared to Q4 FY2017) Consolidated Net Profit up by Rs 67 Cr to Rs 356 Cr (↑ 23 % as
Slide 5: Key Highlights - Continuing Operations (YTD)
Key Highlights - Continuing Operations YTD Mar 18 vs. YTD Mar 17 Consolidated Revenue down by Rs 336 Cr to Rs 10,345 Cr (↓ 3 % as compared to FY2017) Standalone Revenue down by Rs 313 Cr to Rs 3,524 Cr (↓ 8 % as compared to FY2017) Consolidated Net Profit up by Rs 439 Cr to Rs 1,560 Cr (↑ 39 %
Slide 6: Key Events and Outcomes
Key Events and Outcomes Highest ever Launch of value added 2nd Highest Production Production & Sales products Soda Ash (India) Sodium Bicarbonate (India) & • Medicarb (Branded pharma Salt (India) grade Sodium Bicarbonate) • Multi Grain Khichadi Mix • Variants in Spices Urea Transaction Exited Fertil
Slide 7: Key Financials – Quarter ended 31st March 2018
Key Financials – Quarter ended 31st March 2018 Revenue (Rs Cr) EBITDA (Rs Cr) & Margin (%) PAT (Rs Cr) & Margin (%) 550 21% 400 14% 15% 20% 20% 500 11% 18% 300 Consolidated 20% 10% 450 19% 200 400 512 19% 356 2,592 473 288 5% 2,555 18% 100 350 18% 300 17% - 0% Q4 Mar 18 Q4 Mar 17 Q4 Mar 18 Q4 Mar 17
Slide 8: Key Financials – Year ended 31st March 2018
Key Financials – Year ended 31st March 2018 Revenue (Rs Cr) EBITDA (Rs Cr) & Margin (%) PAT (Rs Cr) & Margin (%) 2,200 21% 22% 2,000 20% 21% 15% 20% 2,100 1,500 15% Consolidated 21% 10% 2,000 2,191 20% 1,000 10% 10,681 1,560 10,345 2,094 20% 1,900 500 1,121 5% 19% 1,800 19% - 0% YTD Mar 18 YTD Mar 1
Slide 9: Key Financials – Business Highlights
Key Financials – Business Highlights Consolidated Standalone • TATA Chemicals North America (TCNA) continue to • India Chemicals business continues to perform perform better on the back of improved with healthy margins due to improved operational production and sales volumes, along with better effic
Slide 10: Key Financials – Balance Sheet
Key Financials – Balance Sheet Consolidated Standalone (Rs Cr) 31-Mar-18 31-Mar-17 31-Mar-18 31-Mar-17 ASSETS Non - Current Assets 16,839 16,236 8,484 8,328 Current Assets Inventories 1,462 1,386 451 612 Trade Receivables 1,308 2,092 140 1,032 Cash and Cash Equivalent 3,946 1,451 3,303 1,097 Others
Slide 11: Key Financials – Segment Financials
Key Financials – Segment Financials Consolidated Standalone Inter segment revenue Rs. 7 Cr & Unallocated Rs. 1 Cr Unallocated Rs. 1 Cr Segment Revenue (Rs Cr) 146 146 1,809 Revenue Revenue Rs 10,345 Rs 3,524 Cr Cr 8,396 3,377 Finance Cost Rs. 326 Cr & Net Unallocated Exp./(Income) Rs. 0.4 Cr Finance
Slide 12: Subsidiary Financials
Subsidiary Financials Quarter Ended Mar18 – Continuing Operations Rs Cr India US UK Africa Rallis Consolidated* CY PY CY PY CY PY CY PY CY PY CY PY Revenues 918 939 819 785 368 409 136 106 371 367 2,555 2592 EBITDA 257 162 141 117 78 84 21 14 35 42 512 473 PBT 271 153 68 52 28 49 11 11 25 32 372 346
Slide 13: Debt position as on 31st March 2018
Debt position as on 31st March 2018 6,000 4,000 3,754 Standalone 2,000 1,011 2,411 7 1,407 - (2,347) -2,000 -4,000 Gross Debt Net Change Revaluation Gross Debt Cash & Cash Net Cash Mar'17 Mar'18 Equivalents 10,000 8,000 Consolidated 1,203 178 6,000 4,559 4,000 7,443 6,418 2,000 1,860 - Gross Debt Ma
Slide 14: Volumes: Q4 – Mar 2018 for Key products
Volumes : Q4 – Mar 2018 for Key products Soda Ash volumes (In Kts.) Sodium Bicardonate volumes (In Kts.) 1,000 60 800 50 In Kts 600 400 40 In Kts 200 30 - Mar-18 Mar-17 Mar-18 Mar-17 20 10 Sales Production - TCNA 589 544 578 509 Mar-18 Mar-17 Mar-18 Mar-17 TCML 85 76 87 67 Sales Production TCEHL 78
Slide 15: Volumes: YTD March 2018 for Key products
Volumes : YTD March 2018 for Key products Soda Ash volumes (In Kts.) Sodium Bicardonate volumes (In Kts.) 2,000 250 1,500 200 In Kts 1,000 150 In Kts 500 - 100 Mar-18 Mar-17 Mar-18 Mar-17 50 Sales Production - TCNA 2,350 2,241 2,345 2,216 Mar-18 Mar-17 Mar-18 Mar-17 TCML 336 272 324 300 Sales Produc
Slide 16: General Information
General Information TATA Chemicals - Share Price movement (close) TCL- Market Capitalisation and Nifty 50 Index 52 weeks ↑: 782 52 weeks ↓: 583 Average: 667 TCL - Market Cap Nifty 50 800 20,000 700 15,000 600 10,000 500 400 5,000 Exchange Rate (Average) TATA Chemicals Limited - Shareholding pattern
Slide 17: Contact details
TATA CHEMICALS TATA eg a Living, Industry and Farm Essentials. For any question/queries please contact & John Mulhall & [email protected] © +91 22 6665 8282 & Sameer Kulkarni = [email protected] © +91 226665 7942 & Keya Muriya = [email protected] © +91 226665 7496 & Gavin